FDA's New Cross-Cutting Oncology Center Gets Pazdur As Lead
This article was originally published in The Gray Sheet
Executive Summary
FDA's oncology drug guru Richard Pazdur will be heading a new cancer regulatory center aimed at bringing device, drug and biologics regulators together to support new innovations.